AU8154094A - Methods for inhibiting weight gain or inducing weight loss - Google Patents

Methods for inhibiting weight gain or inducing weight loss

Info

Publication number
AU8154094A
AU8154094A AU81540/94A AU8154094A AU8154094A AU 8154094 A AU8154094 A AU 8154094A AU 81540/94 A AU81540/94 A AU 81540/94A AU 8154094 A AU8154094 A AU 8154094A AU 8154094 A AU8154094 A AU 8154094A
Authority
AU
Australia
Prior art keywords
compound
inhibiting
weight loss
formula
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU81540/94A
Other languages
English (en)
Inventor
Henry Uhlman Bryant
Jeffrey Alan Dodge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU8154094A publication Critical patent/AU8154094A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
AU81540/94A 1993-12-21 1994-12-19 Methods for inhibiting weight gain or inducing weight loss Abandoned AU8154094A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US171291 1993-12-21
US08/171,291 US5578613A (en) 1993-12-21 1993-12-21 Methods for inhibiting weight gain or inducing weight loss

Publications (1)

Publication Number Publication Date
AU8154094A true AU8154094A (en) 1995-06-29

Family

ID=22623225

Family Applications (1)

Application Number Title Priority Date Filing Date
AU81540/94A Abandoned AU8154094A (en) 1993-12-21 1994-12-19 Methods for inhibiting weight gain or inducing weight loss

Country Status (16)

Country Link
US (2) US5578613A (cg-RX-API-DMAC7.html)
EP (1) EP0659423A1 (cg-RX-API-DMAC7.html)
JP (1) JPH07196492A (cg-RX-API-DMAC7.html)
KR (1) KR950016741A (cg-RX-API-DMAC7.html)
CN (1) CN1107707A (cg-RX-API-DMAC7.html)
AU (1) AU8154094A (cg-RX-API-DMAC7.html)
CA (1) CA2138455A1 (cg-RX-API-DMAC7.html)
CZ (1) CZ322294A3 (cg-RX-API-DMAC7.html)
HU (1) HUT71342A (cg-RX-API-DMAC7.html)
IL (1) IL112044A (cg-RX-API-DMAC7.html)
NO (1) NO944923L (cg-RX-API-DMAC7.html)
NZ (1) NZ270182A (cg-RX-API-DMAC7.html)
PH (1) PH31266A (cg-RX-API-DMAC7.html)
RU (1) RU94044357A (cg-RX-API-DMAC7.html)
TW (1) TW272126B (cg-RX-API-DMAC7.html)
ZA (1) ZA9410090B (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6417198B1 (en) 1993-12-21 2002-07-09 Eli Lilly And Company Methods of inhibiting CNS problems in post-menopausal women
US6562862B1 (en) * 1994-10-20 2003-05-13 Eli Lilly And Company Methods of inhibiting physiological conditions associated with an excess of neuropeptide Y
US5900418A (en) * 1997-02-10 1999-05-04 Synapse Pharmaceuticals International, Inc. Method for treatment of obesity
ZA982877B (en) * 1997-04-09 1999-10-04 Lilly Co Eli Treatment of central nervous system disorders with selective estrogen receptor modulators.
US6054446A (en) 1997-12-24 2000-04-25 Sri International Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
US6288108B1 (en) 1998-06-16 2001-09-11 Eli Lilly And Company Methods for increasing levels of acetylcholine
EA200100039A1 (ru) 1998-06-16 2001-06-25 Эли Лилли Энд Компани Способы увеличения уровней ацетилхолина
IL146284A0 (en) 1999-05-04 2002-07-25 Strakan Ltd Androgen glycosides and pharmaceutical compositions containing the same
US20060088860A1 (en) * 2004-09-13 2006-04-27 Lipomics Technologies, Inc. Metabolite markers for weight management
CA2588087A1 (en) * 2004-11-15 2006-05-18 Obe Therapy Biotechnology S.A.S. Methods of reducing body fat
EP2225261B1 (en) 2007-12-03 2016-03-09 Obe Therapy Biotechnology Boropeptide inhibitors of enteropeptidase and their uses in treatment of obesity, overweight and/or diseases associated with an abnormal fat metabolism
US20140378424A1 (en) * 2011-12-30 2014-12-25 Rosscreening, Inc. Estrogen receptor modulators for reducing body weight

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133814A (en) * 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4380635A (en) * 1981-04-03 1983-04-19 Eli Lilly And Company Synthesis of acylated benzothiophenes
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US5075321A (en) * 1987-03-24 1991-12-24 University Of Pennsylvania Methods of treating diseases characterized by interactions of IgG-containing immune complexes with macrophage Fc receptors using antiestrogenic benzothiophenes
US5395842A (en) * 1988-10-31 1995-03-07 Endorecherche Inc. Anti-estrogenic compounds and compositions
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体
TW303299B (cg-RX-API-DMAC7.html) * 1993-07-22 1997-04-21 Lilly Co Eli

Also Published As

Publication number Publication date
HU9403673D0 (en) 1995-02-28
CN1107707A (zh) 1995-09-06
US5578614A (en) 1996-11-26
TW272126B (cg-RX-API-DMAC7.html) 1996-03-11
JPH07196492A (ja) 1995-08-01
HUT71342A (en) 1995-11-28
CA2138455A1 (en) 1995-06-22
PH31266A (en) 1998-06-18
NO944923D0 (no) 1994-12-19
US5578613A (en) 1996-11-26
EP0659423A1 (en) 1995-06-28
NO944923L (no) 1995-06-22
RU94044357A (ru) 1996-10-20
NZ270182A (en) 1996-08-27
KR950016741A (ko) 1995-07-20
CZ322294A3 (en) 1995-09-13
ZA9410090B (en) 1996-06-19
IL112044A (en) 1999-01-26
IL112044A0 (en) 1995-03-15

Similar Documents

Publication Publication Date Title
AU7577994A (en) Methods for inhibiting bone loss
AU7594594A (en) Slip-correcting load-clamping system
AU5734694A (en) Pre-amplifier
AU7309694A (en) Weight distribution hitch
AU7751394A (en) Herbicidal substituted phenylaminosulphonylureas
AU7875494A (en) Method for inhibiting angiogenesis
AU6727494A (en) Isoquinolinetrione derivatives as herbicides
HU9403673D0 (en) Methods for inhibiting weight gain or inducing weight loss
AU3602593A (en) Polyphenol oxidase
AU3385693A (en) Determination method
AU6425394A (en) Sectional-bar system
AU6224194A (en) Blast-cleaning system
AU671899B2 (en) 5-O-desosaminylerythronolide derivative
AU1119495A (en) Game system
AU7460594A (en) High molecular weight desulphatohirudin
AU7883494A (en) Compensation
AU7000294A (en) Herbicidal thiadiazabicyclodecanes
AU7645594A (en) Protective faceshield
AU7467394A (en) Galactosylmoranoline derivative
AU6169294A (en) 15-oxasterols as hypocholesterolemics
AU3460693A (en) Amphotericin B derivative
AU7077694A (en) Disabled/ablebodied photobooth
AU649551B2 (en) Protective case
RU2002850C1 (ru) Быстрорежуща сталь
AU7083594A (en) Galactosylmoranoline derivative